Nasdaq Stockholm

Vitrolife AB

ISIN SE0011205202Filings at the FI

At a glance

Most recent filing on February 6, 2026 — an open-market purchase by Bronwyn Brophy O'Connor on Feb 6, 2026.

We hold 44 visible filings, going back to October 4, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 44 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 44. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Bronwyn Brophy O'Connor Chief executive officer
269,814 SEKOpen-market buy
TradedFeb 6, 2026FiledFeb 6, 2026
Ermanno Sironi Other senior executive
577,642 SEKOpen-market buy
TradedFeb 6, 2026FiledFeb 6, 2026
Pär Svensson Ihrskog Chief financial officer
197,010 SEKOpen-market buy
TradedFeb 4, 2026FiledFeb 4, 2026
Bronwyn O'Connor Chief executive officer
2,495,957 SEKOpen-market buy
TradedSep 13, 2023FiledSep 14, 2023
Patrik Tolf Chief financial officer
535,045 SEKOpen-market buy
TradedApr 26, 2023FiledApr 26, 2023